Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M. Miravitlles, I. Fernández, T. Guerrero, C. Murio.
Desarrollo y resultados de un programa de cribado de la EPOC en atención primaria.
El Proyecto PADOC. Arch Bronconeumol, 36 (2000), pp. 500-505
[2.]
C.J. Murray, A.D. López.
Alternative projection of mortality by cause 1990-2020: global burden of disease study.
Lancet, 349 (1997), pp. 1498-1504
[3.]
S.D. Shapiro.
End-stage chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 164 (2001), pp. 339-340
[4.]
T. Haahtela.
The importance of inflammation in early asthma.
Respiratory Medicine, 89 (1987), pp. 461-462
[5.]
P. Rytila, T. Metso, K. Heikkinen, P. Saarelainen, I.J. Helenius, T. Haahtela.
Airway inflammation in patients with symptoms suggesting asthma but with normal lung function.
Eur Respir J, 16 (2000), pp. 824-830
[6.]
B. Burrows, R.J. Knudson, M.G. Cline, M.D. Lebowitz.
Quantitative relationships between cigarette smoking and ventilatory function.
Am Rev Respir Dis, 115 (1977), pp. 195-205
[7.]
P.M. O'Byrne, D.S. Postma.
The many faces of airway inflammation.
Am J Respir Crit Care Med, 159 (1994), pp. S41-S66
[8.]
G.C. Apostol, D.R. Jacobs, A.W. Tsai, R.S. Crow, D. Williams, M.C. Townsend, et al.
Early life factors contribute to the decrease in lung function between ages 18 and 40.
Am J Respir Crit Care Med, 166 (2002), pp. 166-172
[9.]
P. Lange, J. Parner, J. Vestbo, P. Schnohr, G. Jensen.
A 15-year follow- upe study of ventilation function in adults with asthma.
N Engl J Med, 339 (1998), pp. 1194-1200
[10.]
M. Tracey, A. Villar, L. Dow, D. Coggon, F.C. Lampe, S.T. Holgate.
The influence of increased bronchial responsiveness, atopy and serum IgE on decline in FEV1. A longitudinal study in the elderly.
Am J Respir Crit Care Med, 151 (1995), pp. 656-662
[11.]
M. Saetta.
Airway inflammation in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 160 (1999), pp. S17-S20
[12.]
B.E.A. Lams, A.R. Sousa, P.J. Rees, T.H. Lee.
Subepitelial immunopathology of the airways in smokers with and without chronic obstructive pulmonary disease.
Eur Respir J, 15 (2000), pp. 512-516
[13.]
J. Zhu, Y.S. Quiu, S. Majumdar, E. Gamble, D. Matin, G. Turato, et al.
Exacerbations of bronchitis: bronchial eosinophilia and gene expresión for IL-4, IL-5, and eosinophil chemoattactans.
Am J Respir Crit Care Med, 164 (2001), pp. 109-116
[14.]
M.D. Lebowitz, D.S. Postma, B. Burrows.
Adverse efects of eosinophils and smoking on the natural history of newly diagnosed chronic bronchitis.
Chest, 108 (1995), pp. 55-61
[15.]
M. León Fábregas, A. De Diego Damiá, M. Perpiñá Tordera.
Utilidad del cuestionario de síntomas respiratorios IAUTLD para el diagnóstico diferencial del asma bronquial y la bronquitis crónica.
Arch Bronconeumol, 36 (2000), pp. 441-449
[16.]
H.A. Thiadens, D.S. Postma, G.H. De Bock, D.A. Huysman, H.C. Van Houwelingen, M.P. Springer.
Asthma in adult patients presenting with symptoms of acute bronchitis in general practice.
Scand J Prim Health Care, 18 (2000), pp. 188-192
[18.]
US Department of Health and Human Services, Public Health Service.
National Heart Lung and Blood Institute.
Expert Panel Report II: guidelines for the diagnosis and management of asthma,
[19.]
J.T. Annema, D. Sparrow, G.T. O'Connor, B. Rijcken, G.H. Koeter, D.S. Postma, et al.
Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: The Normative Aging Study.
Eur Respir J, 8 (1995), pp. 62-69
[20.]
J.J. Hospers, D.S. Postma, B. Rijcken, S.T. Weiss, J.P. Schouten.
Histamine airway hiper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study.
Lancet, 356 (2000), pp. 1313-1317
[21.]
A. Nagai, W.M. Thurlbeck, K. Cono.
Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 151 (1995), pp. 635-639
[22.]
P.G. Gibson, M. Fugimura, A. Niimi.
Eosinophilic bronchitis: clinical manifestations and implications for treatment.
Thorax, 57 (2000), pp. 178-182
[23.]
C.E. Brightling, G. Woltman, A.J. Wardlaw, I.D. Pavord.
The development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
Eur Respir J, 14 (1999), pp. 1228-1230
[24.]
M. Linden, J.B. Rasmussen, E. Piitulainen, A. Tunek, M. larson, H. Tegner, et al.
Airway inflammatin in smokers with nonobstructive and obstructive chronic bronchitis.
Am Rev Respir Dis, 148 (1993), pp. 1226-1232
[25.]
P. Chanez, A.M. Vignola, T. O'Shaugnessy, I. Enander, D. Li, P.K. Jeffery, et al.
Corticosteroid reversibility in COPD is related to features of asthma.
Am J Respir Crit Care Med, 155 (1997), pp. 1529-1534
[26.]
E. Pizzichini, M.M.M. Pizzichini, P. Gibson, K. Parameswaran, G.J. Gleich, L. Berman, et al.
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.
Am J Respir Crit Care Med, 158 (1998), pp. 1511-1517
[27.]
S. Matsui, N. Yamashita, M. Maruyama, J. Araya, H. Oda, T. Fujita, et al.
acute eosinophilic pneumonia induced by cigarette smoking: positive lymphocyte stimulation test of a cigarette extract.
Nihon-Kokyuki-Gakkai-Zasshi, 38 (2000), pp. 807-811
[28.]
C.E. Barter, A.H. Campbell.
Reationship of constitutional factors and cigarette smoking to decrease in one-second expiratory volume.
Am Rev Respir Dis, 113 (1976), pp. 305-314
[29.]
N.R. Anthonisen, J.E. Connett, R.P. Murria.
Smoking and lung function of lung health study participants after 11 years.
Am J Respir Crit Care Med, 166 (2002), pp. 675-679
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
